Novel mutations in
Journal
Molecular vision
ISSN: 1090-0535
Titre abrégé: Mol Vis
Pays: United States
ID NLM: 9605351
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
08
2019
accepted:
29
11
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
20
6
2020
Statut:
epublish
Résumé
Cone rod-dystrophies (CRDs) are pigmentary retinopathies mainly involving cones. CRDs typically present with decreased visual acuity and loss of sensitivity in the central visual field, reflecting the primary dysfunction of cones associated with night blindness and concentric visual field loss due to rod dysfunction. We describe the phenotype, natural history, and molecular analysis results of an early onset form of CRD. An otherwise healthy 25-year-old man from Sardinia, Italy, initially presented with subacute visual loss and central scotoma in both eyes. He underwent a complete ophthalmic examination, electrophysiologic testing, and genetic counseling. We first applied a candidate gene approach on The ophthalmic examination was unremarkable except the fundus examination, which revealed a well-circumscribed ring-shaped area of choroidal and RPE atrophy surrounding the fovea in the left eye and small white patches of atrophy around the fovea in the right eye. The ocular features and medical history were consistent with a diagnosis of CRD. Twenty years later, he showed a marked impairment in visual function, secondary to severe atrophic maculopathy associated with sparse pigmentary deposits. Molecular analysis identified two novel frameshift mutations in The mutations in
Substances chimiques
Eye Proteins
0
PCARE protein, human
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
814-820Informations de copyright
Copyright © 2019 Molecular Vision.
Références
Am J Hum Genet. 2000 Oct;67(4):960-6
pubmed: 10958761
BMC Ophthalmol. 2012 May 15;12:8
pubmed: 22587380
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Retina. 2013 Oct;33(9):1871-6
pubmed: 23676993
Hosp Pract (1995). 2000 Jun 15;35(6):41-50, 56-8
pubmed: 10884818
Orphanet J Rare Dis. 2007 Feb 01;2:7
pubmed: 17270046
Eur J Hum Genet. 2015 Dec;23(12):
pubmed: 25873014
Hum Genet. 2001 Sep;109(3):326-38
pubmed: 11702214
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3840-3850
pubmed: 28763557
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Vision Res. 1982;22(12):1417-28
pubmed: 6985105
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7154-9
pubmed: 10852960
Am J Hum Genet. 2010 May 14;86(5):783-8
pubmed: 20398884
Prog Retin Eye Res. 2018 Sep;66:157-186
pubmed: 29597005
Hum Genet. 2001 Apr;108(4):346-55
pubmed: 11379881
Cell. 1997 Nov 14;91(4):543-53
pubmed: 9390563
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Doc Ophthalmol. 2012 Dec;125(3):211-8
pubmed: 22865508
Eur J Ophthalmol. 1999 Oct-Dec;9(4):255-65
pubmed: 10651188
FEBS Lett. 1997 Jun 9;409(2):247-52
pubmed: 9202155
Clin Chem. 2004 Aug;50(8):1336-43
pubmed: 15192030
Arch Ophthalmol. 2009 Dec;127(12):1596-602
pubmed: 20008714
Surv Ophthalmol. 2004 Mar-Apr;49(2):159-96
pubmed: 14998691
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT377-87
pubmed: 27409497
JAMA Ophthalmol. 2015 May;133(5):609-12
pubmed: 25742505